tradingkey.logo

Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports

ReutersMar 7, 2026 12:56 AM

- Wegovy maker Novo Nordisk NOVOb.CO plans to sell its weight-loss drugs on Hims & Hers Health HIMS.N platform, bringing an end to a dispute between the two companies that escalated into a legal battle last month, Bloomberg News reported on Friday.

Novo and Hims plan to announce a new partnership as soon as Monday, the report said, citing a person familiar with the matter.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI